OpenAI has asked third-party contractors to upload real examples of work they produced in past or current jobs to help train ...
January 08, 2026 - PRESSADVANTAGE - Silverback Webinar has announced continued development and refinement of its ...
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
Through vivid fighter pilot stories and actionable insights, the author guides readers through the three phases from ...